"Thymoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)
- Carcinoma, Thymic
- Carcinomas, Thymic
- Thymic Carcinoma
- Thymic Carcinomas
Below are MeSH descriptors whose meaning is more general than "Thymoma".
Below are MeSH descriptors whose meaning is more specific than "Thymoma".
This graph shows the total number of publications written about "Thymoma" by people in this website by year, and whether "Thymoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Thymoma" by people in Profiles.
An Updated Review on Radiation Treatment Management in Thymus Cancers. Clin Lung Cancer. 2022 11; 23(7):561-570.
Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer. 2021 06; 68 Suppl 4:e29042.
Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapy. Immunotherapy. 2021 01; 13(1):11-17.
ATM mutation in a patient with thymoma-associated myasthenia gravis. Muscle Nerve. 2020 08; 62(2):E50-E52.
Ectopic hamartomatous thymoma in an immunocompromised male. Pathol Res Pract. 2019 Sep; 215(9):152497.
A peripheral cause of asthma: Peripheral T-cell lymphoma. Ann Allergy Asthma Immunol. 2019 04; 122(4):420-422.
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma. Clin Lung Cancer. 2018 09; 19(5):e811-e814.
The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma. J Thorac Oncol. 2017 04; 12(4):734-744.
Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016 Mar; 99:332-50.
6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice. Cancer Immunol Immunother. 2015 Aug; 64(8):1033-46.